



and Calebin A can Suppress it in
Colorectal Cancer Cells
Constanze Buhrmann1,2, Aranka Brockmueller1, Choudhary Harsha3,
Ajaikumar B. Kunnumakkara3, Peter Kubatka4, Bharat B. Aggarwal5 and Mehdi Shakibaei1*
1Musculoskeletal Research Group and Tumor Biology, Chair of Vegetative Anatomy, Faculty of Medicine, Institute of Anatomy,
Ludwig-Maximilian-University Munich, Munich, Germany, 2Faculty of Medicine, Institute of Anatomy andCell Biology, University of
Augsburg, Augsburg, Germany, 3Cancer Biology Laboratory and DBT-AIST International Center for Translational and
Environmental Research (DAICENTER), Department of Biosciences and Bioengineering, Indian Institute of Technology Guwahati,
Guwahati, India, 4Department of Medical Biology, Jessenius Faculty of Medicine, Comenius University in Bratislava, Martin,
Slovakia, 5Inflammation Research Center, San Diego, CA, United States
Background: Tumor microenvironment (TME) has a pivotal impact on tumor progression,
and epithelial-mesenchymal transition (EMT) is an extremely crucial initial event in the
metastatic process in colorectal cancer (CRC) that is not yet fully understood. Calebin A (an
ingredient in Curcuma longa) has been shown to repress CRC tumor growth. However,
whether Calebin A is able to abrogate TME-induced EMT in CRC was investigated based
on the underlying pathways.
Methods: CRC cell lines (HCT116, RKO) were exposed with Calebin A and/or a FAK
inhibitor, cytochalasin D (CD) to investigate the action of Calebin A in TME-induced EMT-
related tumor progression.
Results: TME induced viability, proliferation, and increased invasiveness in 3D-alginate
CRC cultures. In addition, TME stimulated stabilization of the master EMT-related
transcription factor (Slug), which was accompanied by changes in the expression
patterns of EMT-associated biomarkers. Moreover, TME resulted in stimulation of NF-
κB, TGF-β1, and FAK signaling pathways. However, these effects were dramatically
reduced by Calebin A, comparable to FAK inhibitor or CD. Finally, TME induced a
functional association between NF-κB and Slug, suggesting that a synergistic
interaction between the two transcription factors is required for initiation of EMT and
tumor cell invasion, whereas Calebin A strongly inhibited this binding and subsequent CRC
cell migration.
Conclusion:We propose for the first time that Calebin A modulates TME-induced EMT in
CRC cells, at least partially through the NF-κB/Slug axis, TGF-β1, and FAK signaling. Thus,
Calebin A appears to be a potential agent for the prevention and management of CRC.
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INTRODUCTION
Colorectal cancer (CRC) is ranked third in incidence and second
in associated mortality worldwide (Bray et al., 2018; Bray et al.,
2020; Siegel et al., 2020). CRC rising incidences have been linked
to the aging population, poor lifestyle, and diet in particular,
among other factors (Dekker et al., 2019). Although, it has been
observed that the incidence of CRC has been decreasing in recent
years (Mauri et al., 2019), additionally it has been reported that
the quality of life is often compromised by chronic side effects in
CRC patients after therapies (Buccafusca et al., 2019). This
indicates the importance of developing an alternative effective
treatment option with few side effects in order to control the
overall CRC mortality statistics.
The major etiological factor of CRC is chronic infection in the
gastrointestinal tract that causes an active pro-inflammatory
tumor microenvironment (TME) supported by defensive cells
such as T-lymphocytes, macrophages, natural killer cells and
other cells that may play a key role in tumor development (Elinav
et al., 2013). The TME contributes significantly to the
proliferation, survival, and migration of the underlying cellular
neoplastic system. In addition, tumor cells possess some of the
signaling proteins of the inherent immune system, such as
chemokines, cytokines and their receptors that contribute to
migration and metastasis (Coussens and Werb, 2002). Further,
the inflammatory TME attracts immune cells and other
protective cells which secrete pro-inflammatory mediators.
These factors, in turn, can lead to greater alteration of
intracellular signaling pathways, initiation and accumulation of
mutations in tumor cells that induce active and rapid
proliferation and protect the cancer cells from apoptosis. As a
result, CRC cells lose the epithelial phenotype and simultaneously
acquire the mesenchymal phenotype, thus undergoing an
epithelial-mesenchymal transition (EMT) that gives them the
ability to metastasize (Virchow, 1881; Coussens and Werb, 2002;
de Visser et al., 2006; Medzhitov, 2008; Buhrmann et al., 2020a).
Therefore, targeting the TME might provide new therapeutic
approaches for controlling tumor development.
EMT and its associated progression and occurrence of
metastasis is a major contributor to mortality in CRC patients,
and the underlying mechanisms are still under exploration. EMT
has been shown to play a determinant function in cancer
development as it leads to disruption of cell-cell adherences,
extracellular matrix (ECM) re-modelling and increased motility
of the tumor cells (Martin, 2014). In addition, EMT inhibits
E-cadherin expression, causing impaired adhesion and cell
polarity during the development of epithelial tumors
(carcinomas) and becomes evident at the stage of invasion
(mesenchymal phenomenon), when tumor cells detach from
the primary tumor and acquire the ability to cross the
surrounding area (Behrens et al., 1992; Stetler-Stevenson et al.,
1993; Christofori and Semb, 1999; Tepass et al., 2000; Thiery,
2002; Prieto-García et al., 2017) and this promotes formation of
cancer stem cells (Mani et al., 2008; Polyak and Weinberg, 2009).
Interestingly, it has been previously reported that down-
regulation of E-cadherin expression in tumor cells may involve
both genetic and epigenetic modifications (Christofori and Semb,
1999). Among the epigenetic and genetic modifications, excessive
methylation of the E-cadherin promoter and transcriptional
suppression are observed as major activities in most
carcinomas (Yoshiura et al., 1995; Tamura et al., 2000; Cheng
et al., 2001; Hajra et al., 2002). In addition, transcriptional
repressors of the Snail zinc finger transcription factor family,
such as Snail and Slug, play an essential role in the activation and
induction of EMT, as this alters the expression patterns of EMT
biomarkers in favor of the mesenchymal phenotype (LaBonne
and Bronner-Fraser, 2000; del Barrio and Nieto, 2002; Nieto,
2002). Indeed, the inflammatory TME has been further shown to
induce cancer initiation, and metastasis through stimulating the
EMT process (Buhrmann et al., 2016). Stromal cells in the TME
are recognized to have a pivotal function in the stimulation of
EMT in tumor cells (Guo and Deng, 2018) and TME-mediated
EMT induction in tumor cells is stimulated by activating various
cell signaling pathways including TNF-β, NF-κB and Wnt
signaling connected with cancer progression (Jing et al., 2011).
Moreover, pro-inflammatory TNF-α or TNF-β, have been
previously reported to act as potential endogenous tumor-
promoting factors and an important mechanism of cytokines
in this action is to induce EMT in different types of tumor cells
(Soria et al., 2011; Buhrmann et al., 2020a). In addition, focal
adhesion kinase (FAK), cytoskeletal proteins and their receptors
have previously demonstrated to have a major function in the
context of EMT-mediated tumor cell survival and invasion, as
well as progression. These upstream signaling molecules are
potential therapeutic targets to control tumor metastasis as
well as tumor proliferation (Seguin et al., 2015).
NF-κB is a very important and pro-inflammatory
transcription factor that is induced by diverse inflammatory
signals, oxidative stress, and various carcinogens in diverse
cells. Moreover, NF-κB is known to initially reside in an
inactive state in the cytoplasm in various cells and consists of
a heterotrimer with p50 and p65 subunits and an inhibitory IκBα
subunit (Bhat-Nakshatri et al., 2010). It has been shown that most
of the processes involved in pro-inflammatory and carcinogenic
pathways are linked to NF-κB signaling. After activation and
phosphorylation, NF-κB translocates to the nucleus to control the
protein expression of pro-inflammatory genes. Interestingly, it is
found that phosphorylation of NF-κB leads to various stages of
inflammation, survival, proliferation, migration, angiogenesis,
tumor development, and also tumor cell metastasis and drug
resistance (Aggarwal, 2004).
The transforming growth factor-β1 (TGF-β1) is identified to
be a potent enabler of EMT in the initial phase of tumor
progression and tumor metastasis (Buhrmann et al., 2016). In
addition, TGF-β1 specifically promotes receptor complex activity,
leading to the initiation of Smad2 phosphorylation in the nucleus,
in which they functionally associate to transcription factors such
as Snail and Slug, suppressing the expression of epithelial
biomarkers and stimulating the expression of mesenchymal
biomarkers at mRNA level (Zhang et al., 2018).
Further, activation of EMT signaling pathways has been
described to be regulated at the epigenetic and post-
translational level (Prieto-García et al., 2017) and identification
of novel agents targeting EMT may provide possible new
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therapeutic approaches in cancer treatment (Kalluri and
Weinberg, 2009). Calebin A [4-(3-methoxy-4-hydroxyphenyl)-
2-oxo-3-enebutanyl 3-(3-methoxy-4-hydroxyphenyl)
propenoate] is drived from curcumin-free turmeric (Curcuma
longa L., Zingiberaceae), first described by Park and Kim (Park
and Kim, 2002) and since then, other isomers of Calebin A have
been discovered (Zeng et al., 2007). Calebin A has been reported
to possess potent anti-inflammatory and anti-tumor potential,
such as inhibiting cell viability, proliferation, and migration, and
promoting apoptosis in various resistant and solid tumor cells by
blocking several cellular signaling pathways (Aggarwal et al.,
2013; Buhrmann et al., 2019; Nair et al., 2019; Buhrmann
et al., 2020a).
However, so far, to our knowledge, there are not any clear
studies published on the possible inhibition of EMT process and
metastasis in CRC-TME by Calebin A. Therefore, the present
study targeted to test the sub-regulatory promotions of Calebin A
on CRC cells in a pro-inflammatory multicellular TMEmodel. In
this work, we report for the first time that Calebin A suppresses
TME-induced invasion and malignancy of CRC cells by




Monoclonal antibodies to phospho-specific-FAK, PARP, p65-
NF-κB, phospho-specific p65-NF-κB, and activated-Caspase-3
were from R&D Systems (Heidelberg, Germany). Antibodies
to β-Actin, cytochalasin D (CD), MTT reagent [3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide], DAPI
(4,6-diamidino-2-phenylindole), dithiothreitol (DTT) and
alginate were from Sigma-Aldrich (Taufkirchen, Germany).
Anti-E-cadherin, anti-vimentin, anti-TGF-β1, anti-p-Smad2
and anti-Slug were from Santa Cruz Biotechnology (Santa
Cruz, CA, United States). Secondary antibodies for
immunofluorescence were procured from Dianova (Hamburg,
Germany). Alkaline phosphatase-linked antibodies for Western
blotting were obtained from EMD Millipore (Schwalbach,
Germany). Calebin A (CA), was a generous gift from Sabinsa
Corporation (East Windsor, NJ, United States). Calebin A was
diluted and 10,000 µM stock solution was prepared in DMSO,
and this was further diluted in cell culture medium. Final
concentration of DMSO did not exceed 0.1% during the
experiments. Focal adhesion kinase inhibitor (FAK-I) (PF-
562271) was purchased from Sellekchem (Munich, Germany).
Stock sample of 10 mM FAK-I was prepared in DMSO and
diluted again in serum-starved medium to make working
samples.
Cell Lines and Cell Culture Conditions
Two distinct colorectal cancer cell lines (HCT116 and RKO), and
a stromal fibroblast cell line (MRC-5) were purchased from the
European Collection of Cell Cultures (Salisbury,
United Kingdom) and a human T-lymphocyte cell line
(Jurkat) was obtained from the Leibniz Institute (DSMZ-
German Collection of Microorganisms and Cell Cultures).
Jurkat was cultured in suspension and HCT116, RKO, and
MRC-5 were cultured as monolayers in normal cell growth
medium containing 10% FCS under standard conditions
(37°C, 5% CO2) (Shakibaei et al., 2015).
Study Design
TME cultures were set up by co-culturing stromal cells (MRC-5),
T-lymphocyte cell line (Jurkat) and CRC cells (HCT116, RKO) to
investigate the potential of Calebin A on the suppression of
epithelial-to-mesenchymal transition in CRC cells as described
previously (Buhrmann et al., 2020a). To establish the
multicellular TME, CRC cells (HCT116, RKO) in 3-
dimensional (3D) alginate cultures (1×106/ml alginate) were
transferred to petri dishes containing monolayer fibroblasts
(3,000/cm2) and in suspension T-lymphocytes (20.000/ml
medium). These cells were cultured in serum-starved medium
(3% FCS) for 10 days. The CRC cells cultured in alginate beads
alone were termed as “basal control”. All experiments were
performed with serum starved medium containing only 3% FCS.
Alginate Culture
As described in detail in our previous studies (Shakibaei and De
Souza, 1997; Shakibaei et al., 2015), CRC cells (1x106/ml) were
suspended in alginate and dropwise (size: 0.5 cm) added into a
sterile CaCl2 solution (100 mM) where the drops polymerized
into beads after 10 min. After continued washing with NaCl
(15 mM), alginate beads were incubated for 1 h in serum
starved medium. For the experiments, cells were left untreated
or treated with CD in a dose dependent manner (0.1, 1, 2, and
4 µg/ml) for 30 min and then encapsulated in alginate beads, and
TME cultures were established as described above. Further,
primarily untreated TME cultures were treated with Calebin A
(1, 2, 5, and 10 µM) or with FAK-I (0.01, 0.1, 1, and 10 µM). As
basal control, CRC were encapsulated in alginate beads without
fibroblasts or Jurkat and either left untreated or treated with 5 µM
Calebin A. Medium was changed three times a week and cultures
were investigated after 10 days.
Viability Assay
Impact of Calebin A on the proliferation of CRC cells in TME
cultures was examined by the MTT reagent, as described before
(Buhrmann et al., 2020a). Shortly, CRC cells treated as described
above were detached from alginate using a sterile sodium citrate
solution (55 mM), were re-suspended in altered medium (no
phenol red, no vitamin C, 3% FCS) and 10 μl MTT solvent (5 mg/
ml) was spread per well in a 96-well plate in triplicate. Incubation
was stopped after 2 h by adding 10% Triton x-100/acidic
isopropanol and metabolically active cells were estimated using
a multiscanner plate ELISA reader (Bio-Rad Laboratories Inc.
Munich, Germany).
Invasion Test
The cell invasion assay was examined using alginate beads
(Shakibaei et al., 2015; Buhrmann et al., 2020a). Shortly, 1
x106/ml cells were embedded in alginate and treated as
described above. After incubation for 10 days, the noninvasive
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cells and alginate matrix were removed from the petri dishes
while the invasive cells that migrated across the alginate beads
adhered and made colonies in opposite to fibroblasts cells on the
bottom of the petri dish. These invasive cells were stained with
toluidine blue for 1 h and accurate washed two times with PBS
and photographed under the light microscope (Zeiss, Germany).
The amount of migrating and positively stained attached colonies
was quantified and analyzed by counting all colonies.
Immunofluorescence
Immunofluorescence labeling of Slug was performed in a
modified TME as described (Buhrmann et al., 2020a). Shortly,
HCT116, and RKO cells were seeded on glass plates (5,000/plate)
and after adherence, they were either left untreated or treated
with CD (1, 2 µg/ml) for 30 min and then placed on a steel-net
bridge in petri dishes containing monolayer of fibroblasts
(10.000/cm2) and T-lymphocytes in suspension (20.000/ml) to
establish TME. Additionally, cultures were either left untreated or
treated with Calebin A (1, 5 µM) for 24 h. For basal control, CRC
cells were cultured only on glass plates without creating the TME
and either left untreated or were treated with Calebin A (5 µM).
Western Blot Analysis
Samples from the TME were processed in the same manner as
earlier detailed (Shakibaei et al., 2015; Buhrmann et al., 2017).
Shortly, alginate samples were suspended in sterile sodium citrate
solution for 20 min, lyzed on ice (50 mM Tris/HCl, pH 7.2/
150 mM NaCl/(v/v) Triton X-100/1 mM sodium orthovanadate/
50 mM sodium pyrophosphate/100 mM sodium fluoride/4 µg/ml
pepstatin A/1 mM PMSF), total protein content was measured,
and fractionated by SDS-PAGE under reducing conditions. After
blotting on a nitrocellulose membrane (Transblot apparatus, Bio-
Rad, Munich, Germany), membranes were incubated overnight
with primary antibody (1:10,000) at 4°C and incubated for 1.5 h
with secondary antibody (1:10,000). Positive binding was
determined using nitroblue tetrazolium and 5-bromo-4-chloro-
3-indoyl phosphate (VWR, Germany), quantification of bands
was performed using the “Quantity One” program (Bio-Rad,
Munich, Germany).
DNA-Binding Assay
To address the role of Calebin A in modulating NF-κB
attachment on DNA, we performed a DNA-binding assay with
dithiothreitol (DTT) as earlier detailed (Buhrmann et al., 2020a).
TME cultures were established and then nuclei and cytoplasm
were separated from each other, from CRC cells that remained
untreated and/or treated with Calebin A (1, 2, and 5 µM) plus
DTT (5 mM) alone or in both for 1 h, as has been thoroughly
outlined in previous work (Buhrmann et al., 2020a; Buhrmann
et al., 2020b; Buhrmann et al., 2020c). The nuclei were then
prepared, separated by SDS-PAGE and blotted as indicated
earlier. PARP was used to normalize the samples to the controls.
Immunoprecipitation Assay
The immunoprecipitation assay was performed as outlined
(Shakibaei et al., 2012) to explore the endogenous interaction
of NF-κB and Slug on CRC grown in TME cultures. Whole cell
extracts of HCT116 and RKO from TME cultures were incubated
with 25 µl of either normal rabbit IgG-serum or normal mouse
IgG-serum and Staphylococcus aureus cells as pre-clearing.
Further, samples were incubated with primary antibodies
(anti-p-NF-κB-p65 or anti-Slug) diluted in washing buffer
[0.1% Tween 20, 150 mM NaCl, 50 mM Tris-HCl (pH 7.2),
1 mM CaCl2, 1 mM MgCl2 and 1 mM PMSF] for 1.5 h (4°C),
with S. aureus cells for 1 h and washed three times with washing
buffer and once with 50 mM Tris-HCl (pH 7.2). Finally, samples
were boiled in SDS-PAGE sample buffer and immunoblotting
(anti-p-NF-κB-p65 or anti-Slug) was performed as described
above. Additionally, samples were incubated with non-
immune rabbit anti-mouse IgG alone as control
immunoprecipitations.
Statistics
Each individual assay was tested separately three times using
three separate sets of replicates. A Wilcoxon-Mann-Whitney test
was used for statistical analysis. Results were presented as mean ±
SD or SEM and compared by one-way, two-way or three-way
ANOVA using SPSS Statistics if the normality test was satisfied
(Kolmogorov-Smirnov test). A p-value of <0.05 was regarded as
evidence of statistically important results.
RESULTS
The objective of this presentation was to investigate the sub-
regulatory actions of Calebin A (a component of C. longa)
(Figure 1A) on CRC cells in a pro-inflammatory multicellular
TME model to represent an in vivo approach TME. In this work,
we show for the first time that Calebin A suppresses TME-
induced CRC cell invasion and malignancy by modulating
EMT signaling during the early onset of CRC.
Calebin A Blocks TME-Induced Viability and
Proliferation of CRC Cells, Comparable to
FAK Inhibitor or Cytochalasin D
Given that the organization and rearrangement of the
cytoskeleton is essential for the cancer cell invasion,
migration, and proliferation (Tai et al., 2015), we first
investigated whether Calebin A modifies colorectal cancer
cell proliferation and viability in TME, similar to FAK
inhibitor or cytochalasin D. Serum-starved HCT116 or RKO
cells were kept untreated or treated with different
concentrations of Calebin A or FAK inhibitor or CD. Cell
viability and proliferation were determined using MTT assay
as outlined in Materials and Methods. TME significantly
increased cell viability and proliferation of HCT116 and RKO
cells compared with basal control (Figures 1B,C). In contrast,
Calebin A, similar to FAK inhibitor, or CD reduced markedly
TME-promoted cell viability and proliferation of cells in 3D-
alginate tumor cultures in both basal control and TME in a
dose-dependent way. Collectively, the anti-proliferative action
of Calebin A resembles FAK inhibitor or cytochalasin D and
these proteins may play a role in its efficacy.
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FIGURE 1 |Calebin A or FAK inhibitor or cytochalasin D action on colorectal cancer cell survival. (A)Chemical bodies of Calebin A. (B)HCT116 and (C)RKO cells in
alginate beads by themselves (basal control B. Co.) or in TMEwere firstly not treated, and secondly, were exposed to a series of doses of Calebin A (CA) (1, 2, 5, 10 μM)
or cytochalasin D (CD) (0.1, 1, 2, and 4 µg/ml) or FAK inhibitor (FAK-I) (0.01, 0.1, 1, and 10 µM) for 10 days and cell survival was monitored by MTT. All tests were
checked on three different occasions each. *p < 0.05, **p < 0.01 relative to basal control.
FIGURE 2 | Calebin A or cytochalasin D actions on colorectal cancer cells migration in TME. (A) HCT116 and (B) RKO cells in alginate beads by themselves (Basal
Co.) or in TME were treated with increasing concentration of Calebin A (CA) (1, 2, and 5 μM), of cytochalasin D (CD) (0.1, 1, and 2 µg/ml) or culture medium as control for
10 days in alginate and migrated spheroids were identified by toluidine blue-based labeling as outlined in the Materials and Methods. Results of all tests were scored at a
minimum of three counts. *p < 0.05, **p < 0.01 relatively to basal control.
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Calebin A Blocks TME-Induced 3D-Alginate
CRC Cell Migration and Invasion,
Comparable to Cytochalasin D
To assess the action of Calebin A or CD on the motility and
invasion ability of CRC cells through the TME, HCT116, and RKO
cells were grown in a 3D-alginate-matrix TME that more closely
represents in vivo conditions and handled as outlined in detail in
Materials and Methods. As shown in Figures 2A,B, the untreated
TME significantly promoted tumor cell migration in CRC cell
through the 3D-alginate-based matrix compared with the basal
untreated TME control. In contrast, treatment of CRC cells with
Calebin A (1, 2, and 5 µM), similar to CD (0,1, 1, and 2 µg/ml),
blocked CRC cell migration and invasion across the alginatematrix
in TME cultures in a dose-dependent way. Taken together, this is
consistent with the results of the MTT assay, which showed that
Calebin A, similar to CD inhibited CRC cell viability and
proliferation, and these data highlight the importance of the
involvement of cytoskeletal signaling proteins in the anti-
metastasis properties supported by Calebin A in TME.
Calebin A Down-Regulated EMT-Related
Transcription Factor (Slug) in CRC Cells
Comparable to Cytochalasin D, as Shown
by Immunofluorescence Microscopy
Slug is a component of the Snail generation of zinc-finger
transcription factors (Blanco et al., 2002), and it has been
proposed that Slug is participating in the modulation of cell
motility during tumor cell invasion and migration (Cobaleda
et al., 2007). To explore the impact of Calebin A on Slug
expression in CRC cells, HCT116 and RKO cultures were left
untreated or treated with different concentrations of Calebin A or
CD and immunolabeled with anti-Slug as described above and
evaluated by immunofluorescence microscopy and nuclear
labeling with DAPI. In the control TME cultures, HCT116
and RKO cells showed significantly stronger labeling for Slug
in the nucleus compared with the basal control (Figures 3A–C).
Calebin A treatment, similarly to CD, significantly downregulated
the expression of Slug in CRC cells and its nuclear localization in
TME cultures, indicating the important pro-inflammatory effects
of TME on CRC cells that support tumor promotion. Taken
together, these results highlight that Slug is one of themajor target
proteins of Calebin A for its anti-metastatic or anti-EMT
mechanisms in CRC cell TME (Figures 3A–C). Apoptosis was
in fact verified by analyzing the apoptosis indicating
morphological alterations in the nucleus with DAPI nuclear
labeling (Figures 3A–C). Nuclear staining showed that
untreated control HCT116 (Figures 3A,B) and RKO
(Figure 3C) cell cultures had generally normal nuclear
dimensions with only a few apoptotic nuclei in the cultured
cells. In contrary, a significant increase in apoptotic cells was
observed in cells treated with Calebin A or CD in HCT116 or
RKO cells with nuclear morphological alterations (pyknosis,
fragmented nuclei, chromatin condensation) in a dose-
dependent fashion (Figures 3A–C). Taken together, these
FIGURE 3 |Calebin A or cytochalasin D action on EMT-related transcription factor (Slug) expression in colorectal cancer cells. HCT116 (A–B) and RKO (C) cells by
themselves (basal co.) subjected to Calebin A (CA) (5 µM), or in TME were kept alone untreated, subjected to graded doses of Calebin A (CA) (1, 5 μM) or cytochalasin D
(CD) (1, 2 µg/ml) for 4 h in monolayer cultures and underwent immunofluorescence staining with anti-Slug and nuclear counterstaining with DAPI as stated in the
Materials and Methods of this study. Magnification 400x; bars  30 nm. All assays were performed three times each, and the number of apoptotic nuclei (arrows)
has been determined by scoring 400–500 cells taken at 25 separate microscopic areas (B–C). *p < 0.05, **p < 0.01 compared to basal control.
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outcomes are in agreement with MTT findings and indicate
Calebin A has the ability to act to suppress the pro-tumor
actions of TME in CRC cells through repression of EMT as
well as induction of apoptosis.
Calebin A Suppressed TME-Induced
p-NF-κB-p65, FAK, and Activated
TME-Inhibited Caspase-3, Comparable to
Cytochalasin D, in CRC Cells
In the past, TMEs have been shown to promote NF-κB activation
and phosphorylation, which has been linked to tumor cell
migration and metastasis (Ghosh et al., 1998; Lind et al., 2001;
Cho et al., 2007; Sutnar et al., 2007). Therefore, we investigated
the expression and phosphorylation of NF-κB in relation to
malignancy and metastasis of CRC cells. Starved HCT116 and
RKO cells were grown in alginate matrix beads and co-cultured in
TME conditions, followed by treatment with incremental
concentrations of Calebin A (1, 2, and 5 μM), CD (0.1, 1, and
2 µg/ml) or in culture medium as a control for 10 days as detailed
in the Materials and Methods. Samples were immunolabeled
using antibodies to p65, phospho-specific p65-NF-κB, p-FAK,
and Caspase-3.
The levels of p65-NF-κB and p-FAK phosphorylation of
HCT116 and RKO-alginate cultures were found to be notably
increased in TME compared with basal control cultures.
Interestingly, in a manner consistent with the disruption of
the cytoskeleton by CD, treatment of TME with Calebin A
markedly down-regulated the phosphorylation of p-NF-κB-p65
and p-FAK in a concentration-dependent way in both cells
(Figure 4). Calebin A based treatment of TME, similar to CD
disruption of the cytoskeleton, significantly upregulated cleaved
Caspase-3 protein expression in CRC cells in a dose-dependent
way (Figure 4). Contrary, treatment with CD resulted in less
cleaved Caspase-3 protein compared with Calebin A, and
cleavage of Caspase-3 was greater in RKO than in HCT116
CRC cells (Figure 4). These results suggest that Calebin A
suppresses TME-mediated migration and invasion in CRC
cells via inhibition of NF-κB, p-FAK and stimulation of
caspase-3.
Calebin A Modulated TME-Induced TGF-β1
Signaling, Comparable to Cytochalasin D in
CRC Cells
The cytokine transforming growth factor-β1 (TGF-β1) is a
crucial factor in tumor progression and a strong enhancer of
EMT during tumor invasion and metastasis (Massagué, 2000;
Siegel and Massagué, 2003; Derynck and Akhurst, 2007),
therefore, next, to determine whether TGF-β1 is implicated
in augmenting tumor cell proliferation, migration, and the
factors that stimulate cancer, we studied TGF-β1 protein
expression in HCT116 and RKO cells. Starved cells grown in
the TME cultures were either kept untreated or treated as
mentioned in the “Materials and Methods” paragraph. Both
CRC cells exhibited low expression of TGF-β1 and p-Smad-2
proteins in basal control (Figure 5). Whereas, immunoblotting
showed substantially increased levels of TGF-β1 and p-Smad-2
FIGURE 4 | Calebin A or cytochalasin D actions on NF-κB, FAK, and caspase-3 expression in colorectal cancer cells. (A) HCT116 and (B) RKO cells in alginate
beads (B. Co.) or in TME were kept by themselves or treated with variable amounts of Calebin A (CA) (1, 2, and 5 μM) or cytochalasin D (CD) (0.1, 1, and 2 µg/ml) for
10 days as outlined in Materials andMethods. Immunoblotting on total samples was performed throughWestern blotting using antibodies to p65-NF-κB, phospho-p65-
NF-κB, p-FAK, and Caspase-3. Indicated are the results of at least three separate assays, with β-Actin serving as control. The densitometric analysis has been
carried out for the indicated proteins. *p < 0.05, **p < 0.01 relatively to basal control.
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expression in both HCT116 and RKO cells obtained by TME
(Figure 5). Importantly, in a manner resembling CD-treated
cultures, Calebin A was found to considerably down-regulate
the expression of the biomarkers mentioned above in a
concentration-dependent way (Figure 5). Taken together,
these outcomes are consonant with those of several other
studies documenting that TGF-β1 and cytokines are the
major contributors to progression, invasion, and metastasis
within the TME (Derynck and Akhurst, 2007; Li et al., 2014;
Jang et al., 2015). Collectively, Calebin A acts against the TMEs
and has a potent suppressive effect on the mentioned processes.
Calebin A Modulated TME-Induced Altering
the Expression of EMT-Specific
Biomarkers, Comparable to Cytochalasin D
in CRC Cells
To learn more about the multifunctional role of the Calebin
A, in TME-induced tumor malignancy and metastasis in
CRC cells, in relation to motility and EMT, we examined the
level of EMT-related pathway protein expression, including
E-cadherin, vimentin, and Slug. EMT has been reported to
have a major function in carcinogenesis by leading to
FIGURE 5 |Calebin A or cytochalasin D actions on TGF-β1 and p-Smad-2 expression in colorectal cancer cells. (A)HCT116 and (B)RKO cells in alginate beads (B.
Co.) or in TME were maintained untreated or treated as outlined to the previous. Immunoblotting of total samples was performed by Western blotting using antibodies to
TGF-β1 and p-Smad-2. Indicated are the results of at least three separate assays, with β-Actin serving as loading control. Densitometric analysis was performed for the
indicated proteins. *p < 0.05, **p < 0.01 relatively to basal control.
FIGURE 6 |Calebin A or cytochalasin D actions on EMT-specific biomarkers in colorectal cancer cells. HCT116 (A) and RKO cells (B) in alginate beads (B. Co.) or in
TME were maintained alone or treated as outlined to the previous. Immunoblotting of total samples was performed by Western blotting using antibodies to E-Cadherin,
vimentin and Slug. Indicated are the results of at least three separate assays, with β-Actin serving as loading control. Densitometric analysis was performed for the
indicated proteins. *p < 0.05, **p < 0.01 relatively to basal control.
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weakening of cell-cell adhesion, alteration of ECM, and
increased motility of cancer cells (Martin, 2014). We
investigated the expression of EMT biomarkers for
tumorigenicity and the possible effects of Calebin A on
these biomarkers. Alginate basal control HCT116 and
RKO cells revealed a basal level expression of the
aforementioned EMT markers (Figure 6). In contrast,
Western blot results showed markedly down-regulated
expression of E-cadherin and markedly up-regulated
expression of vimentin and Slug in both cells from TME
cultures (Figure 6). However, similar to CD, treatment with
Calebin A resulted in up-regulation of E-cadherin
expression and, in contrast, significant down-regulation
of vimentin and Slug expression in a concentration-
dependent way, indicating the prominent targeting
impact of Calebin A on the EMT signaling pathway
(Figure 6). The densitometric analysis of the
immunoblots supported the presented findings
(Figure 6). Taken together, such data clearly demonstrate
the critical function of Calebin A in regulating TME-
stimulated EMT pathway, as well as Calebin A mediates
anti-metastasis effects in part by down-regulating the EMT
pathway of CRC cells in the TME.
DTT Blocks Calebin A-Suppressive Effects
of NF-κB Binding to DNA in CRC Cells
We further wanted to know whether Calebin A has the ability
to trigger the repression of NF-κB phosphorylation by
directly interfering with its binding to DNA. To address
this question, we treated isolated nuclei obtained from
HCT116 (A) and RKO (B) cells as indicated in Materials
and Methods. To this end, Calebin A markedly attenuated the
association of NF-κB binding to DNA in a dose-dependent
way, as demonstrated in Figures 7A,B. Since the position 38
cysteine region in p65 protein is required for DNA binding,
an assay to remove the cysteine regions was performed with
DTT either with or without Calebin A. Indeed, our study
revealed that the blocking effect of Calebin A toward the
attachment of p65-NF-κB on DNA has been abolished when
DTT was applied to the nuclei of RKO cells, similar to
HCT116 cells, indicating a specific effect of Calebin A in
regulating the interaction of NF-κB with DNA and this is not
cell specific (Figures 7A,B). Taken together, these data
suggest that Calebin A directly modulates the binding of
p65-NF-κB to DNA.
Calebin A Inhibits TME-Induced
p-NF-κB-p65 Association With the Master
EMT-Related Transcription Factor (Slug),
Comparable to Cytochalasin D in CRC Cells
Cell motility, cytoskeletal remodeling, cell adhesion, FAK
signaling pathways, and NF-κB have already been shown to
be linked to the regulation of cancer cell growth, viability, and
invasiveness (Cary and Guan, 1999; Schlaepfer et al., 1999;
Cheng et al., 2001; Aggarwal, 2004; Zhang et al., 2009). The
functional link between the proteins that have a metastasis-
promoting effect in the TME and their contribution to cancer
metastasis is known. We next performed co-
immunoprecipitation experiment to provide evidence for a
potentially interaction of NF-κB and Slug in CRC cells in
TME. Cells were treated as described in Materials and
Methods, and cell lysates immunoprecipitated using
antibodies directed to p-NF-κB or to Slug, that was
subsequently immunoblotted using Slug or p-NF-κB
antibodies. As shown in Figure 8, surprisingly, in both
CRC cells, we found markedly strong co-
immunoprecipitation of NF-κB protein with Slug protein
in TME (Figure 8). Marginal co-immunoprecipitation of
NF-κB protein with the Slug protein was observed in
untreated basal control cultures (Figure 8). However,
similar to CD, treatment with Calebin A significantly
inhibited this co-immunoprecipitation of NF-κB protein
with Slug protein. Densitometric analysis of immunoblots
supported the results presented at the top (Figure 8). Overall,
our data strongly indicate that, on the one hand TME
promotes the formation of the NF-κB/Slug complex during
tumorigenesis, resulting in malignancy and metastasis in
CRC cells, and, on the other hand Calebin A prevents
TME-induced EMT, partly due to blockage of the NF-κB/
Slug route.
FIGURE 7 | Calebin A acts on TME-induced p-NF-κB-p65 engagement with DNA in colorectal cancer cells. (A) HCT116 and (B) RKO cells in alginate beads were
cultured alone (B. Co.) or in TME were cultured alone or subjected to Calebin A (CA) as outlined in the Materials and Methods. Dissected nuclei of basal control or TME
cells that has been allowed to incubate for 30 min with the stated concentrations of Calebin A in the presence or absence of 5 mM DTT were processed, then examined
for p-NF-κB-p65 linkage to DNA using Western blotting. PARP acted as control. Densitometric assessment was done for the indicated proteins. *p < 0.05, **p <
0.01 relatively to basal control.
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DISCUSSION
The present work has allowed us to establish a CRC cell 3D-
alginate pro-inflammatory multicellular TME culture mimicking
the heterogeneous TME in vivo to evaluate the anti-tumor actions
observed with Calebin A, mainly the anti-EMT effect. We
provided the following insights and investigated the role of
TME in promoting CRC tumor progression (tumor migration
and EMT) and the modulatory actions of Calebin A in this
process. 1) The TME induced viability, proliferation, and
alterations in the expression of biomarkers related to EMT
(elevated vimentin, depressed E-cadherin), leading to higher
motility and invasiveness in CRC cells. 2) However, these
effects were dramatically decreased by Calebin A, similar to
FAK inhibitor or CD. 3) In addition, TME induced
stabilization of master EMT-related transcription factor (Slug),
activation of NF-κB, increased TGF-β1- and p-Smad-2-
expression, and FAK signaling pathways. 4) Calebin A
treatment, similar to CD, significantly reduced TME-induced
NF-κB, FAK and Slug signaling and cell migration in both CRC
cell lines as well. 5) Calebin A selectively down-regulated the
binding of p65-NF-κB on DNA in the two CRC cells, thereby
modulating NF-κB-dependent TME-induced EMT signaling. 6)
Finally, TME induced a functional connection between NF-κB
and Slug, which could enhance Slug-dependent up-regulation of
EMT, whereas Calebin A, similar to CD strongly blocked this
association of the two transcription factors, thereby
blocking EMT.
It has been repeatedly shown in the recent past that three-
dimensional tumor cultures have excellent culture conditions
compared to two-dimensional tumor cultures, as these cultures
have a set of suitable in vivo conditions for tumor cell survival
(Luca et al., 2013; Shakibaei et al., 2015; Stankevicius et al., 2017).
The alginate-based substrate provides the appropriate 3D
microenvironment for tumor cells to proliferate, form typical
tumor spheroids and, very importantly, provides conditions for
tumor cells to migrate through the alginate substrate and
eventually metastasize. Interestingly, the alginate bead culture
is solubilized readily and the living CRC tumor cells can be tested
as to their multiple properties in the early steps of proliferation
and metastasis further supporting the TME in a manner
comparable to in vivo (Shakibaei et al., 2015; Buhrmann et al.,
2016).
Increasing evidences indicate that there is a direct strong link
between inflammation, inflammatory mediators and
tumorigenesis. However, the mechanisms by which TME and
inflammation enable tumor progression remain poorly
understood. It is now recognized that inflammation-induced
migration, EMT and metastasis of tumor cells in the TME is a
major target of many clinical challenges in tumor treatment
FIGURE 8 | Calebin A or cytochalasin D impact on TME-induced p-NF-κB-p65 association with master EMT-related transcription factor (Slug) in colorectal cancer
cells. HCT116 (A) and RKO (B) cells in alginate matrix alone (B. Co.) or in TME were kept without treatment (Co.) or treated with Calebin A (CA) or Cytochalasin D (CD) as
outlined in the Materials andMethods. The lysate samples were immunoprecipitated (IP) using anti-p-NF-κB-p65 or with anti-Slug. Finally, each immunoprecipitates was
fractionated by SDS-PAGE and subjected to immunoblotting (IB) with anti-Slug or anti-p-NF-κB-p65. Densitometric assays on protein levels as displayed with
immunoblotting were carried out in triplicate. The initial samples were subjected to antibody against β-Actin as control. Values were comparable with the reference
control. p < 0.05 (*), p < 0.01 (**). IgH  immunoglobulin heavy chain.
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(Cordon-Cardo and Prives, 1999; Coussens and Werb, 2002;
López-Novoa and Nieto, 2009). In this report, we have shown
in invasion assays that the TME induced invasion of cells and this
was significantly down-regulated through Calebin A, similar to
CD or FAK-inhibitor. This similar mode of action of Calebin A
and CD is due to an important target in the cell, namely
cytoskeletal proteins, which are critical and essential for cancer
cell proliferation, migration and invasion and thus EMT (Tai
et al., 2015). This target of Calebin A was further confirmed by the
fact that Calebin A also simultaneously inhibits the enzyme
responsible for polymerization of cytoskeletal proteins, FAK.
In addition, focal contacts are membrane-bound complex
structures that create connection among the cytoskeleton and
the ECM. FAK plays an essential role as an integrator of
biochemical signals and mechanical stimuli and also
dominates in active and motile cells. Furthermore, FAK found
to have an integral function in controlling DNA synthesis and
cytoskeletal organization, thereby regulating cell division,
proliferation, and migration (Zhao et al., 1998; Oktay et al.,
1999). However, it has been shown that high expression of
FAK and FAK signal transduction pathways in various tumor
cells and tumor stem cells results in anti-apoptotic effects and
tumor cell survival. Indeed, FAK plays a fundamental role in
modulating tumor aggressiveness and metastasis, and high FAK
expression is always associated with a negative prognosis of
tumors (Hungerford et al., 1996; Almeida et al., 2000; Sonoda
et al., 2000; Kong et al., 2015; Tai et al., 2015).
We also demonstrated that the transcription factor NF-κB is
one of the important stimulated inflammatory down-stream
signaling pathways for TME. Similar to the CD pathway,
Calebin A has a specific modulatory effect against TME-
promoted activation of NF-κB pathway as well as NF-κB-
regulated proteins in CRC cells. This finding and our previous
studies are consistent with previous research demonstrating that
NF-κB becomes activated in tumor cells in responding to diverse
groups of pro-inflammatory substances, including cytokines and
TME, and inhibits apoptosis (Baeuerle and Baichwal, 1997;
Buhrmann et al., 2019; Buhrmann et al., 2020a). After its
translocation into the nucleus, it associates with the targeted
sequence in DNA, leading in turn to gene transcription. It has
already been reported that NF-κB is a promising target for the
development of anti-tumor drugs (Van Antwerp et al., 1996;
Wang et al., 1996). Indeed, TME-induced NF-κB, is known to be
among the major mediators of cancer progression, and thus
proliferation and EMT. Thus, NF-κB is associated with tumor
metastasis (Pikarsky et al., 2004; Wu and Zhou, 2010). Therefore,
compounds like Calebin A, which can block the phosphorylation
of NF-κB, have the ability to block tumor promotion and
metastasis.
Our data further showed that cytokine transforming growth
factor-β1 (TGF-β1) and simultaneously, p-Smad-2 expression
was significantly up-regulated in TME in both CRC cells. Indeed,
it has been previously reported that TME-induced TGF-β1
expression in CRC cells in a Smad2-dependent process (Jang
et al., 2015), and it is known to play a major role in TGF-β1-
induced tumor progression, migration, and EMT (Li et al., 2014).
TGF-β1 induces the signaling pathway for EMT via a heteromeric
complex of two transmembrane serine/threonine kinase
receptors type I and type-II. This leads to phosphorylation of
Smad2 and 3 and 4, whereupon these trimers are transported to
the nucleus, where they associate with transcription factors such
as Snail and Slug to repress the expression of epithelial markers
and induce the expression of mesenchymal markers at the mRNA
level (Zhang et al., 2018). Moreover, TGF-β1 has been shown to
promote tumor cell progression and metastasis mainly through
EMT and EMT-linked proteins during tumor invasion and
metastasis (Buhrmann et al., 2016; Kaowinn et al., 2017).
Interestingly, the concomitant expression of epithelial cell
marker (E-cadherin) was markedly decreased and the
expression of mesenchymal biomarkers (vimentin and Slug)
was markedly increased in the TME. Indeed, down-regulated
E-cadherin expression is known to be a specific feature of the
EMT process in tumorigenesis (Bendris et al., 2012). Our results
clearly show that Calebin A reversed TME-induced changes in
the expression of TGF-β1, p-Smad-2, and EMT biomarkers,
similar to CD, in a concentration-dependent manner,
suggesting that TME-stimulated EMT can be attenuated in
CRC cells. Furthermore, available evidence has recently clearly
demonstrated that both genetic and epigenetic influences and
factors play important roles in silencing E-cadherin expression in
various tumor types (Christofori and Semb, 1999; Cheng et al.,
2001). Indeed, it has been further reported that there are some
inhibitors of E-cadherin such as the Snail family of zinc finger
transcription factors. These transcription factors, as well as Slug,
have now been shown to be important modulators of EMT and
many other important processes via the influence on E-cadherin
in various tumors (Batlle et al., 2000; Cano et al., 2000;
Grooteclaes and Frisch, 2000; Comijn et al., 2001; Perez-
Moreno et al., 2001; Blanco et al., 2002). It was further
reported and clearly demonstrated that Slug, a major EMT-
related transcription factor, has a specific repressive effect on
the mouse E-cadherin promoter. Besides, overexpression of Slug
in MDCK cells and breast cancer cell lines have been reported to
significantly repress endogenous E-cadherin expression, thereby
significantly inhibiting cell EMT (invasion and migration) (Hajra
et al., 2002; Bolós et al., 2003).
Moreover, our data show that the TME clearly induces the
expression of EMT-related transcription factors such as Slug and
NF-κB, indicating targeted EMT activation, and they are known
to be highly expressed especially in tumor stem cells and invaded
tumor cells (Bhat-Nakshatri et al., 2010; Jang et al., 2015), and
Calebin A suppressed the TME-induced expression of Slug and
NF-κB. Indeed, a large body of literature indicates that TME-
induced cytokines and pro-inflammatory signaling may promote
tumor cell metastasis and EMT signaling (Virchow, 1881;
Coussens and Werb, 2002; de Visser et al., 2006; Medzhitov,
2008; Balkwill, 2009; Buhrmann et al., 2020a).
We demonstrated further that TME strongly augmented CRC
cell migration and invasion by triggering the EMT signaling
pathway via NF-κB-mediated Slug axis stabilization and
activation, which plays a critical role in CRC cell metastasis.
These results suggest that a synergistic functional interaction of
Slug and NF-κB is required for initiation of EMT and migration
of tumor cells. However, when the 3D-alginate CRC tumor cells
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were treated with Calebin A, similar to CD, NF-κB/Slug-axis-
activation was markedly inhibited, EMT-related protein
expression was significantly reversed, and TME-stimulated
active migration and invasion were dramatically reduced.
CONCLUSION
In conclusion, our results report the first evidence that Calebin A
can attenuate the TME-promoted EMT, invasion in CRC cells in
3D-alginate beads, similar to CD or FAK-inhibitor via regulation
of FAK, EMT biomarkers, and TGF-β1/Smad-2 expression. The
inhibitory effect of Calebin A on TME-induced EMT is also
associated with suppression of the NF-κB/Slug axis pathway.
Thus, as a multitargeted component, Calebin A is a promising
therapeutic phytopharmaceutical for the treatment of CRC
(Figure 9).
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